Literature DB >> 18288186

Imaging of atherosclerotic cardiovascular disease.

Javier Sanz1, Zahi A Fayad.   

Abstract

Atherosclerosis is characterized by thickening of the walls of the arteries, a process that occurs slowly and 'silently' over decades. This prolonged course of disease provides a window of opportunity for diagnosis before symptoms occur. But, until recently, only advanced atherosclerotic disease could be observed. Now, developments in imaging technology offer many enticing prospects, including detecting atherosclerosis early, grouping individuals by the probability that they will develop symptoms of atherosclerosis, assessing the results of treatment and improving the current understanding of the biology of atherosclerosis.

Entities:  

Mesh:

Year:  2008        PMID: 18288186     DOI: 10.1038/nature06803

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  207 in total

1.  Noninvasive coronary imaging for atherosclerosis in human immunodeficiency virus infection.

Authors:  Ahmed M Gharib; Khaled Z Abd-Elmoniem; Roderic I Pettigrew; Colleen Hadigan
Journal:  Curr Probl Diagn Radiol       Date:  2011 Nov-Dec

2.  Fluorescence lifetime imaging for the characterization of the biochemical composition of atherosclerotic plaques.

Authors:  Jennifer Phipps; Yinghua Sun; Ramez Saroufeem; Nisa Hatami; Michael C Fishbein; Laura Marcu
Journal:  J Biomed Opt       Date:  2011-09       Impact factor: 3.170

3.  Transcriptional regulation of beta2-microglobulin demonstrated via a novel genomic and proteomic analysis of percutaneously collected peripheral atheroma.

Authors:  Brian L Stauffer; Erich J Kushner; Ted Wulfman; Thomas Zeller; Rebecca Sobus; Christian M Westby
Journal:  Clin Transl Sci       Date:  2008-12       Impact factor: 4.689

4.  Stimulated Raman photoacoustic imaging.

Authors:  Vladislav V Yakovlev; Hao F Zhang; Gary D Noojin; Michael L Denton; Robert J Thomas; Marlan O Scully
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

5.  Electrochemical impedance spectroscopy to characterize inflammatory atherosclerotic plaques.

Authors:  Fei Yu; Xiaohu Dai; Tyler Beebe; Tzung Hsiai
Journal:  Biosens Bioelectron       Date:  2011-09-16       Impact factor: 10.618

Review 6.  Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques.

Authors:  Shann S Yu; Ryan A Ortega; Brendan W Reagan; John A McPherson; Hak-Joon Sung; Todd D Giorgio
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011-08-10

7.  Feasibility of (18)F-Fluorodeoxyglucose radiotracer dose reduction in simultaneous carotid PET/MR imaging.

Authors:  Mootaz Eldib; Jason Bini; Olivier Lairez; David D Faul; Niels Oesingmann; Zahi A Fayad; Venkatesh Mani
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-06-15

8.  Assessment of Targeted Nanoparticle Assemblies for Atherosclerosis Imaging with Positron Emission Tomography and Potential for Clinical Translation.

Authors:  Yongjian Liu; Hannah P Luehmann; Lisa Detering; Eric D Pressly; Alaina J McGrath; Deborah Sultan; Annie Nguyen; Susannah Grathwohl; Monica Shokeen; Mohamed Zayed; Robert J Gropler; Dana Abendschein; Craig J Hawker; Pamela K Woodard
Journal:  ACS Appl Mater Interfaces       Date:  2019-04-19       Impact factor: 9.229

9.  Intravascular photoacoustic imaging of exogenously labeled atherosclerotic plaque through luminal blood.

Authors:  Doug Yeager; Andrei Karpiouk; Bo Wang; James Amirian; Konstantin Sokolov; Richard Smalling; Stanislav Emelianov
Journal:  J Biomed Opt       Date:  2012-10       Impact factor: 3.170

10.  Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia.

Authors:  Massimo Torreggiani; Huixian Liu; Jin Wu; Feng Zheng; Weijing Cai; Gary Striker; Helen Vlassara
Journal:  Am J Pathol       Date:  2009-09-24       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.